ALLMedicine™ Haemophilus Influenzae Center

Sep 18th, 2021 - Three hexavalent vaccines against diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B virus (HBV), and Haemophilus influenzae type b (Hib) are licensed in Europe: Infanrix hexa (DT3aP-HBV-IPV/Hib), Hexyon (DT2aP-HBV-IPV-Hib) and Vaxelis (DT...

Sep 13th, 2021 - This study aimed to report on in vitro susceptibility patterns among corneal isolates collected in the Antibiotic Resistance Monitoring in Ocular micRoorganisms (ARMOR) study. Each year, from 2009 to 2019, Staphylococcus aureus, coagulase-negative...

Sep 12th, 2021 - Nasopharyngeal (NP) colonization with Streptococcus pneumoniae and nontypeable Haemophilus influenzae (NTHi) is common in children and may evolve as the source of invasive infections. In Korea, the pneumococcal conjugate vaccines (PCVs) had been i...

Sep 2nd, 2021 - Reduction in detection of asymptomatic carriage of Haemophilus influenzae type b (Hib) can be used to assess vaccine impact. In Nepal, routine vaccination against Hib in children at 6, 10, and 14 weeks of age was introduced in 2009. Before vaccine...

Sep 2nd, 2021 - As part of the global Invasive Bacterial Vaccine-Preventable Diseases Surveillance Network, 12 African countries referred cerebrospinal fluid (CSF) samples to South Africa's regional reference laboratory. We evaluated the utility of real-time poly...

Feb 7th, 2020 - On December 21, 2018 the Food and Drug Administration (FDA) licensed a hexavalent combined diphtheria and tetanus toxoids and acellular pertussis (DTaP) adsorbed, inactivated poliovirus (IPV), Haemophilus influenzae type b (Hib) conjugate (meningo...

Mar 22nd, 2013 - Meningococcal disease describes the spectrum of infections caused by Neisseria meningiditis, including meningitdis, bacteremia, and bacteremic pneumonia. Two quadrivalent meningococcal polysaccharide-protein conjugate vaccines that provide protect...

Oct 3rd, 2008 - On June 20, 2008 the Food and Drug Administration (FDA) licensed a combined diphtheria and tetanus toxoids and acellular pertussis adsorbed (DTaP), inactivated poliovirus vaccine (IPV), and Haemophilus influenzae type b conjugate (tetanus toxoid [...

Feb 23rd, 2008 - Although laparoscopic splenectomy (LS) has become the standard approach for most splenectomy cases, some areas still remain controversial. To date, the indications that preclude laparoscopic splenectomy are not clearly defined. In view of this, th...

Jun 3rd, 2021 - Use of antimicrobials among COVID-19 patients should be assisted by clear guidelines to reduce the risk of drug-resistance, experts said. Patients had a median age of 74. The timing of infection was recorded either as occurring prior to hospitalis...

Apr 29th, 2021 - Guidelines on appropriate short-course antibiotics in common infections were published in April 2021 by the American College of Physicians in the Annals of Internal Medicine.[1,2] Chronic Obstructive Pulmonary Disease and Uncomplicated Bronchitis ...

Jan 10th, 2020 - In 2000, pneumococcal conjugate vaccine 7 (PCV7) was introduced in the United States, and in 2010, PCV13 was introduced. When each of those vaccines were used, they reduced acute otitis media (AOM) incidence caused by the pneumococcal types includ.

Aug 19th, 2019 - The US Food and Drug Administration (FDA) has approved lefamulin (Xenleta, Nabriva Theraputics), a new oral and intravenous (IV) antibiotic for the treatment of adults with community-acquired bacterial pneumonia (CABP). Lefamulin is a first-in-cla...

Aug 19th, 2019 - The US Food and Drug Administration (FDA) has approved lefamulin (Xenleta, Nabriva Theraputics), a new oral and intravenous (IV) antibiotic for the treatment of adults with community-acquired bacterial pneumonia (CABP). Lefamulin is a first-in-cla...